PSOLAR, the Psoriasis Longitudinal Assessment and Registry, is a multicenter, longitudinal, intercontinental, disease-based registry used to identify adverse events from commonly used psoriasis drugs.1 An evaluation of the risk of serious infection from systemic psoriasis treatments was recently published using data from PSOLAR. Ninety-three institutional review boards or ethics committees reported into the registry from…
Search results for: type 1 diabetes
Data Collection Drives Evaluation of Psoriasis Treatments
For six years, the Psoriasis Longitudinal Assessment and Registry (PSOLAR) has collected data to assess the infection risk for drugs treating systemic psoriasis.
FDA Issues Safety Alerts for Bisphosphonates & SGLT2 Inhibitors
Safety The Food and Drug Administration (FDA) has updated the Warnings and Precautions sections of prescribing information for the bisphosphonate agents, including risedronate sodium tablets and combinations with calcium (Actonel/Atelvia), alendronate and combinations with vitamin D (Binosto/Fosamax), ibandronate (Boniva), etidronate (Didronel) and the RANK-ligand inhibitor denosumab (Prolia/Xgeva).1 This information relates to an increased risk for…
Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate
Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists
Giant Cell Arteritis Challenging to Diagnose, Manage
Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets
The Rheumatologist as Detective
A case of difficult-to-diagnose Whipple’s disease
Apolipoprotein E Polymorphism Associated with Hyperuricemia in Chinese Population
Researchers find link between hyperuricemia and higher serum uric acid levels in patients with APOE ε2ε3 genotype and APOE-ε2 allele
Sugary Soft Drinks Can Raise Risk of Rheumatoid Arthritis
Study finds consuming one or more sugar-sweetened sodas daily can increase women’s chance of developing seropositive RA by more than 60%
Google Glass Has Potential for Rheumatology, Orthopedic Surgery
Wearable smart-glass device could enable untethered access to electronic health records, be conduit for clinical decision making
Gout, Glucose Metabolism and Obesity: A Case Review
New research explores association between hyperurecimia and gout with metabolic derangement
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 30
- Next Page »